7月16日，直觉外科公司盘后下跌3.32%，报388.62美元/股，成交额3022.32万美元。消息面上，公司第二季度财报于当日盘后正式发布，股价在财报公布后出现明显回落。此前盘中阶段，受医疗设备板块集体反弹及财报前资金抢筹驱动，公司股价曾上涨3.16%至403.21美元。值得注意的是，近期多家投行密集下调公司目标价，BTIG将目标价由574美元下调至512美元，加拿大皇家银行由650美元下调至600美元，瑞穗由525美元下调至500美元，当前均值目标价约559美元。公司一季度收入同比增长23%至27.7亿美元，经调整每股收益2.5美元均超预期，全年手术量增速指引维持13.5%至15.5%。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.